持续质量改进在血液透析患者肾性贫血治疗中的作用研究

Continues the quality improvement to treat at the hemodialysis patient kidney anemia the function to study

目的：探讨持续质量改进（CQI）在维持性血液透析（MHD）患者肾性贫血治疗中的作用.方法： 通过横断面调查了解MHD患者肾性贫血情况,运用PDCA四步法制定CQI护理干预方案,实施CQI.结果： 在95例MHD患者中,CQI前后静脉铁剂使用率分别为38 9% vs 74.7%（P〈0.05）,EPO使用率分别为83.2% vs 87.4%（P〉0.05）;血红蛋白平均水平分别为（97.2±13.8）g/L vs （112.7±21.2）g/L（P〈0.01）,血清铁蛋白分别为（128.3±56.2）μg/L vs （201.3 ±87.5）μg/L（P〈0.01）,血红蛋白和血清铁蛋白达标率明显升高.结论：实施CQI可有助于提高MHD患者肾性贫血的治疗效果.

Objective：The discussion continues the quality to improve （CQI） to treat at the maintenance hemodialysis （MHD） patient kidney anemia the function. Methods：Through the cross section investigation understood the MHD patient kidney anemia situation,formulates the CQI nursing intervention plan using the PDCA four steps,implements CQI. Results： In 95 example MHD patient,around CQI the vein iron tonic utilization ratio respectively is 38.9 % vs the 74.7 % （P〈0.05）, EPO utilization ratio respectively is 83.2% vs 87.4%（P〉0.05） ;The hemoglobin average level respectively is （97.2±13.8）g/L vs （112.7±21.2）g/L（P〈0. 01） ,the blood serum ferric albuminate iron albuminate respectively is （128.3±56.2）？ g/L vs （201.3 ±87.5）？ g/L（P〈0.01）,hemoglobin and blood serum ferric albuminate iron albuminate success rate obvious ascension. Conclusion： Implements CQI to be possible to be helpful in enhancing the MHD patient kidney anemia the treatment result.